Q: I've seen your team recommend ABBV a few times recently, why do you find this company appealing at this time especially compared to the other pharma cos.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Thoughts on SZLS going forward? Thanks...
Q: Hi Team,
Can you comment on the acquisition this morning? Seems like a relatively significant revenue boost although not much EBITDA...
Thanks!
Can you comment on the acquisition this morning? Seems like a relatively significant revenue boost although not much EBITDA...
Thanks!
Q: What do you see as the outlook for this company?
Q: What is the explanation for the drop, or inconsistency, of quarterly revenue from CRSP and is this a concern?
2019-09: $ 211 M
2019-12: $ 77 M
2020-03: $ 0.157 M
2020-06: $ 0.044 M
2020-09: $ 0.148 M
Their annual revenue in 2019 was $ 289.59 M and it does not look like they will come anywhere close to that number in 2021!
Thanks.
2019-09: $ 211 M
2019-12: $ 77 M
2020-03: $ 0.157 M
2020-06: $ 0.044 M
2020-09: $ 0.148 M
Their annual revenue in 2019 was $ 289.59 M and it does not look like they will come anywhere close to that number in 2021!
Thanks.
Q: FDA approved LUPUS NT. Sell or Hold the stock ? Thanks
Q: Comments on earnings?
- Invitae Corporation (NVTA)
- CRISPR Therapeutics AG (CRSP)
- Twist Bioscience Corporation (TWST)
- ARK Genomic Revolution ETF (ARKG)
Q: I currently own some ARKG and CRSP. If you were to buy a few more individual stocks in this space and had a long term time frame and high risk tolerance what would you buy?
Q: Hi,
Your views on BAX-N on long term. Do you prefer any other name over BAX-N in health sector?
Thanks
Piyush
Your views on BAX-N on long term. Do you prefer any other name over BAX-N in health sector?
Thanks
Piyush
Q: While just about everything is taking a beating today, DOC is up over 8% today on more than twice the average daily volume......Any news? I'm not seeing anything.
Thanks
Dave
Thanks
Dave
Q: PLX is an Israeli Bio co. not showing in your system.
I bought a small position 6 months ago as I am very interested in the diseases they are working to try to alleviate and potentially cure. It has gone up in price nicely this week after company update to shareholders.
Would appreciate your views. Is this a hold or worth buying more at this stage. John.
I bought a small position 6 months ago as I am very interested in the diseases they are working to try to alleviate and potentially cure. It has gone up in price nicely this week after company update to shareholders.
Would appreciate your views. Is this a hold or worth buying more at this stage. John.
Q: In response to your answer to Richard on Reliq, according to the company website, from a corporate presentation document, “management and other insiders” at the Company own 8% of the outstanding shares.
Q: I have 25000 shares of this co. What do you think of it?
Q: do you see any chance of a recovery for these two stocks, or best just to move on? they are in a RRSP account so no chance for tax loss.
thanks Dave
thanks Dave
Q: Hello Peter, Ryan, and 5i Team,
I know you haven't been a big fan of these two companies in the past, due to some questionable management issues before they split from Patient Home Monitoring. However, Viemed shares have surged since listing on the Nasdaq (with some help from Covid) and PTQ has shown recent momentum with last week's announcement of a pending Nasdaq listing. Could you please give me your current thoughts on these two companies? Specifically, does the potential for a cross-listing gain with PTQ outweigh some of the other concerns, or would you still be wary? Thanks, Brad
I know you haven't been a big fan of these two companies in the past, due to some questionable management issues before they split from Patient Home Monitoring. However, Viemed shares have surged since listing on the Nasdaq (with some help from Covid) and PTQ has shown recent momentum with last week's announcement of a pending Nasdaq listing. Could you please give me your current thoughts on these two companies? Specifically, does the potential for a cross-listing gain with PTQ outweigh some of the other concerns, or would you still be wary? Thanks, Brad
Q: Hello team,
Of the 3 companies above, BEAM has 3 times more shares sold short (18% of the float) but all three have been on a run.
If you could buy only one which one would you choose today as a great company for a long-term hold and which one you would rather avoid? And of course why?
Thanks for making investment accessible for ordinary people.
Of the 3 companies above, BEAM has 3 times more shares sold short (18% of the float) but all three have been on a run.
If you could buy only one which one would you choose today as a great company for a long-term hold and which one you would rather avoid? And of course why?
Thanks for making investment accessible for ordinary people.
Q: Can you please give me your view on these two stocks. There has not been too many questions on them on your list.. Speculative, is there a future, etc.
- Illumina Inc. (ILMN)
- Invitae Corporation (NVTA)
- CRISPR Therapeutics AG (CRSP)
- Twist Bioscience Corporation (TWST)
Q: In your answer to a question recently asked on Genomics, your suggestion was to buy an ETF such as ARKG or EAGB. You also mentioned that if so inclined you could start adding small amounts in specific stocks which of course be riskier. Would you be able to suggest 3 or 4 of these stocks either US or Canadian, preferably at least one of each.
Q: Comments on SIS, please.
I see the x div date is Dec 30, when is the next one? I'm think of taking some gains and maybe picking it back up when it gets boring again.
I see the x div date is Dec 30, when is the next one? I'm think of taking some gains and maybe picking it back up when it gets boring again.
Q: Here is a good presentation on Sernova from the president. It touches on market size. Talks about potentials revenue streams and their thoughts on market sizing. A fun number was "untapped $2B market". I'm in since 0.42.
https://journey.ct.events/view/3a577711-041b-48a3-8b1c-0d47129bb30c
The two big ones:
- Type 1 diabetes
- Hyperthyroidism and Hashimoto's
https://journey.ct.events/view/3a577711-041b-48a3-8b1c-0d47129bb30c
The two big ones:
- Type 1 diabetes
- Hyperthyroidism and Hashimoto's